Skip to main content
. 2013 Jul 1;11:110. doi: 10.1186/1477-7525-11-110

Table 1.

Baseline demographics and patient characteristics

Characteristic Tapentadol prolonged
Oxycodone controlled
release (n = 978) release (n = 999)
Mean ± SD age, years
56.8 ± 12.22
56.7 ± 12.39
Age category, n (%):
 
 
<65 years
719 (73.5)
731 (73.2)
≥65 years
259 (26.5)
268 (26.8)
Gender, n (%)
 
 
   Female
639 (65.3)
601 (60.2%)
   Male
339 (34.7)
398 (39.8)
Race, n (%)
 
 
   White
803 (82.1)
813 (81.4)
   Black
111 (11.3)
101 (10.1)
   Hispanic
40 (4.1)
58 (5.8)
   Other
24 (2.5)
27 (2.7)
Pain condition, n (%)
 
 
   Osteoarthritis knee pain
663 (67.8)
673 (67.4)
   Low back pain
315 (32.2)
326 (32.6)
   Mean ± SD pain intensity score *+
7.4 ± 1.26
7.3 ± 1.21
Pain intensity category, n (%) + ~
 
 
   Mild
2 (0.2)
0
   Moderate
119 (12.2)
123 (12.3)
   Severe
854 (87.6)
873 (87.7)
Prior opioid experience, n (%)
 
 
   No
641 (65.5)
681 (68.2)
   Yes 337 (34.5) 318 (31.8)

*Average pain score (11 point numerical rating scale) recorded over the last 72 hours prior to randomisation.

+ Tapentadol n = 975, oxycodone n = 996.

~ Mild pain intensity defined as 1 to <4 on the numerical rating scale, moderate >4 to <6 and severe ≥6.